Filtering by
- All Subjects: Terrorism
- Creators: School of Historical, Philosophical and Religious Studies
- Member of: Theses and Dissertations
The Shining Path, or Sendero Luminoso, is peculiar among Latin American revolutions for a multitude of reasons, ranging from the intensity of its violent tactics to the group’s muddled Maoist ideology. Analyses of the group tend to label it a mystery or an enigma. The purpose of this thesis is to offer the charismatic nature of the authority wielded by Abimael Guzmán, the energetic leader of the group also known as Presidente Gonzalo, as an explanation for some of the Shining Path’s idiosyncrasies, particularly their relentlessly bloodthirsty rise and sharp decline. Although much of the previous literature on the Shining Path uses the word “charismatic” to describe Guzmán, very little work has analyzed the particular implications of the successful creation of a charismatic leader-follower dynamic as a key part of senderismo. Using the framework established by German sociologist Max Weber, this paper analyzes a number of major characteristics of charismatic leaders and applies them to Guzmán. Not only did he exhibit many of the typical features of a charismatic leader, but it may have been is successful development of this particular style of authority which led to both the bloodthirstiness of Sendero’s military arm and the group’s struggle to find an identity after Guzmán’s capture. The Shining Path followed the power arc expected of a charismatic leader-follower relationship, allowing Guzmán to exploit the peasant population to create chaos and fear in the Andes in his effort to bring about a “popular revolution.” The purpose of this paper is not to discredit other theories regarding Sendero, as it was largely a sui generis movement, but to argue several of its particular qualities can be attributed to the charismatic nature of Presidente Gonzalo’s authority.
Pediatric anxiety disorders are highly prevalent and while pharmacological intervention seems to be an effective treatment, the validity of reported adverse side effects remains unclear. <br/><br/>Objective: To analyze the nature of evidence regarding adverse side effects in the pharmacological treatment of pediatric anxiety disorders. <br/><br/>Approach: A search using Google Scholar, PubMed, and PsychInfo was conducted for meta-analyses of pharmacological treatment of pediatric anxiety disorders as well as randomized controlled trials. The focus was on adverse events.<br/><br/>Results and Conclusion: Reportings of a limited number of adverse events were found among resources available to clinician and patient informed sources to inform pharmacological treatment of pediatric anxiety disorders. Only a small fraction of adverse side effects were found in the research literature. This finding raises concerns about making informed decisions to treat pediatric anxiety disorders with pharmacotherapy.